Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06296147 · ClinicalTrials.gov registry record · NA

Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy

A NA study of Prostate Cancer, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
208
Enrollment target
1
Study location

NCT06296147 is a NA study of Prostate Cancer that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 208 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06296147, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
208 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate if a VR headset and/or aromatherapy can be used to reduce patient pain, anxiety, and embarrassment during a transperineal biopsy (TPBx) compared to standard of care (SOC). The primary objective is to evaluate differences in self-reported pain, fear, or embarrassment during and after the procedure between the VR Group, Aromatherapy Group, VR+Aromatherapy Group, and the Control group.

Conditions Studied

Interventions

  • OTHER Standard of Care
  • OTHER Virtual Reality Headset
  • OTHER Aromatherapy Patch

Study Locations (1)

Pennsylvania

  • University of Pittsburgh Medical Center Shadyside Hospital - Pittsburgh

Trial Details

FieldValue
Enrollment Target 208 participants
Start Date 2024-05-20
Est. Completion 2026-05-01
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT06296147

The ClinicalTrials.gov registry entry for NCT06296147 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (66% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 3 interventions - of which Standard of Care is the first listed.

NCT06296147 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06296147 about?

NCT06296147 is a clinical study titled "Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy". The purpose of this study is to evaluate if a VR headset and/or aromatherapy can be used to reduce patient pain, anxiety, and embarrassment during a transperineal biopsy (TPBx) compared to standard of care (SOC). The primary objective is to evaluate differences in self-reported pain, fear, or embarr...

What is the current status of trial NCT06296147?

This trial is currently recruiting. It is a NA study. The enrollment target is 208 participants. The study started on 2024-05-20. Estimated completion is 2026-05-01.

What conditions does trial NCT06296147 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT06296147?

The interventions under investigation include: Standard of Care (OTHER), Virtual Reality Headset (OTHER), Aromatherapy Patch (OTHER).

Who is sponsoring clinical trial NCT06296147?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06296147 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.